Ralph Weichselbaum to Clinical Trials as Topic
This is a "connection" page, showing publications Ralph Weichselbaum has written about Clinical Trials as Topic.
Connection Strength
0.474
-
Oligometastasis: Past, Present, Future. Int J Radiat Oncol Biol Phys. 2020 11 01; 108(3):530-538.
Score: 0.112
-
Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy. J Clin Oncol. 2013 Apr 10; 31(11):1384-90.
Score: 0.066
-
Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials? Nat Clin Pract Gastroenterol Hepatol. 2009 Jan; 6(1):38-46.
Score: 0.049
-
Ionizing radiation: a genetic switch for cancer therapy. Cancer Gene Ther. 2006 Jan 01; 13(1):1-6.
Score: 0.040
-
Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy. Lancet Oncol. 2002 Nov; 3(11):665-71.
Score: 0.032
-
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks? Radiat Res. 2020 11 10; 194(5):452-464.
Score: 0.028
-
Methodological Development of Combination Drug and Radiotherapy in Basic and Clinical Research. Clin Cancer Res. 2020 09 15; 26(18):4723-4736.
Score: 0.027
-
Gene therapy of cancer. Lancet. 1997 May; 349 Suppl 2:SII10-2.
Score: 0.022
-
Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer. Semin Oncol. 1995 Jun; 22(3 Suppl 6):47-52.
Score: 0.019
-
Nanomedicine for Combination Therapy of Cancer. EBioMedicine. 2015 May; 2(5):366-7.
Score: 0.019
-
Predictors of competing mortality in early breast cancer. Cancer. 2010 Dec 01; 116(23):5365-73.
Score: 0.014
-
Vascular endothelial growth factor pathway. Pharmacogenet Genomics. 2010 May; 20(5):346-9.
Score: 0.013
-
Control of gene therapy by MDR1 and EGR1 promoter sequences in transcriptional targeting by chemotherapy (Review). Int J Oncol. 2004 Mar; 24(3):731-6.
Score: 0.009
-
Genetically engineered HSV in the treatment of glioma: a review. Rev Med Virol. 2000 Jan-Feb; 10(1):17-30.
Score: 0.007
-
Timing and sequencing of chemoradiotherapy. Cancer Treat Res. 1995; 74:173-98.
Score: 0.005
-
Combined modality therapy of head and neck cancer. Semin Oncol. 1994 Jun; 21(3):349-58.
Score: 0.004
-
Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer. J Clin Oncol. 1989 Jul; 7(7):838-45.
Score: 0.003
-
Chemotherapy of advanced salivary gland neoplasms. Cancer. 1982 Dec 01; 50(11):2261-4.
Score: 0.002
-
Role of chemotherapy in the multidisciplinary approach to advanced head and neck cancer: potentials and problems. Ann Otol Rhinol Laryngol. 1981 Sep-Oct; 90(5 Pt 1):506-11.
Score: 0.002
-
Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate-leucovorin prior to definitive radiotherapy or surgery. Laryngoscope. 1981 Jul; 91(7):1181-90.
Score: 0.002